Newsroom

Sorted by: Latest

-

Mexedia S.p.A. Società Benefit: Mexedia Intensifies Activities Within the Group’s Development Path

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), further to what was communicated to the market on 9 April 2026 regarding the evaluations initiated within the framework of its development path, announces that the analysis and assessment activities are continuing actively, in line with the strategic directions pursued by the Company. Over recent weeks, Mexedia has intensified discussions and evaluation activities relating...
-

Mexedia S.p.A. Società Benefit : Mexedia intensifie les activités dans le cadre du parcours de développement du Groupe

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), faisant suite à la communication publiée le 9 avril 2026 concernant les évaluations engagées dans le cadre de son parcours de développement, informe que les activités d’analyse et d’approfondissement se poursuivent activement, conformément aux orientations stratégiques poursuivies par la Société. Au cours des dernières semaines, Mexedia a intensifié les discussions et les a...
-

SES Announces Extraordinary General Meeting of Shareholders

LUXEMBOURG--(BUSINESS WIRE)--SES: Société Anonyme RCS Luxembourg B 81267 Notice is hereby given of the Extraordinary General Meeting of SES, Société Anonyme, to be held at the Company's registered office at Château de Betzdorf, L-6815 Betzdorf (the "Company"), Luxembourg, on Wednesday 17 June 2026 at 3:00 p.m. CET AGENDA Attendance list, quorum and adoption of the agenda Nomination of a secretary and of two scrutineers Cancellation of shares purchased in connection with the buy-back programme o...
-

Samenvatting: Meiji Seika Pharma komt met positieve resultaten van de fase III-studie Integral-1 met nacubactam, een nieuwe β-lactamase-remmer, bij gecompliceerde urineweginfecties of acute ongecompliceerde pyelonefritis ― Gepubliceerd in The Lancet

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (hoofdkantoor in Tokio; president en vertegenwoordigend directeur: Toshiaki Nagasato) heeft vandaag bekendgemaakt dat de resultaten van de Integral-1-studie, een van de twee wereldwijde fase III-klinische onderzoeken naar de werkzaamheid en veiligheid van zijn nieuwe β-lactamase-remmer nacubactam (ontwikkelingscode: OP0595), zijn gepubliceerd in The Lancet. Het artikel heeft als titel "Efficacy and safety of cefepime–nacubactam and aztreonam–...
-

Tourism Authority of Thailand Leverage Alipay+ AI Solutions to Accelerate Digital Travel Transformation for Thailand

SINGAPORE--(BUSINESS WIRE)--The Tourism Authority of Thailand (TAT) Beijing Office and Alipay+ launch a campaign to enhance the digital travel experience via AI-generated themes....
-

Cinemo Honored with 2026 AutoX Award for Automotive Infotainment Innovation

KARLSRUHE, Germany--(BUSINESS WIRE)--Cinemo, global leader in AI-powered, fully integrated in-vehicle entertainment and digital media solutions, delivering seamless multi-screen experiences for drivers and passengers, has been recognized as an Automotive Infotainment Innovator at the 2026 AutoX Innovator Awards by Compass Intelligence, highlighting its role in shaping the next generation of in-vehicle experiences. The AutoX Innovator Awards recognize companies that move the industry forward. Wi...
-

First Trust Portfolios UK Regulatory Announcement: First Trust Global Portfolios Management Limited Announces Distribution for certain sub-funds of First Trust Global Funds ICAV

LONDON--(BUSINESS WIRE)--  First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the monthly distribution for First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF (the “Fund”). ISIN Fund Name Frequency Dividend per Share IE000SNMGYT5 First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF Class B Monthly $0.1403 (USD) The Fund’s investment manager is First Trust Advisors L.P. (“FTA”). FTA has appointed Vest Financial LLC...
-

Experian Partners With ServiceNow to Scale Trusted Decisioning to Agentic AI

LONDON--(BUSINESS WIRE)--Experian, the global data and technology company, and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today unveil a new global multi-year partnership which harnesses the power of autonomous AI agents across platforms, helping businesses make faster and smarter decisions at scale. Through this partnership, autonomous AI agents can gain the ability to act faster, and more consistently, starting with employee onboarding, third-party risk management...
-

YOUNG & CO'S BREWERY PLC UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  15 May 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that between 8 May – 14 May 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Stifel Nicolaus Eur...
-

Polska misja gospodarcza z wizytą u Westinghouse i Bechtel w USA

Waszyngton, DC--(BUSINESS WIRE)--W tym tygodniu firmy Westinghouse Electric Company i Bechtel gościły w Stanach Zjednoczonych polską misję gospodarczą z udziałem przedstawicieli kierownictwa Polskich Elektrowni Jądrowych (PEJ) oraz czołowych polskich firm z sektora przemysłowego. Celem wizyty było pogłębienie współpracy transatlantyckiej w obszarze energetyki jądrowej. Kilkudniowa misja, zorganizowana przez Nuclear Energy Institute oraz Polską Izbę Gospodarczą Energetyki i Ochrony Środowiska i...